Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics
Editat de Hae Won Kim, A. Gerson Greenburgen Limba Engleză Paperback – 3 sep 2016
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 930.27 lei 6-8 săpt. | |
Springer Berlin, Heidelberg – 3 sep 2016 | 930.27 lei 6-8 săpt. | |
Hardback (1) | 936.50 lei 6-8 săpt. | |
Springer Berlin, Heidelberg – 9 ian 2014 | 936.50 lei 6-8 săpt. |
Preț: 930.27 lei
Preț vechi: 1134.47 lei
-18% Nou
Puncte Express: 1395
Preț estimativ în valută:
178.04€ • 187.83$ • 148.37£
178.04€ • 187.83$ • 148.37£
Carte tipărită la comandă
Livrare economică 02-16 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783662508077
ISBN-10: 3662508079
Pagini: 769
Ilustrații: XXIII, 746 p. 130 illus., 77 illus. in color.
Dimensiuni: 155 x 235 x 39 mm
Greutate: 1.06 kg
Ediția:Softcover reprint of the original 1st ed. 2013
Editura: Springer Berlin, Heidelberg
Colecția Springer
Locul publicării:Berlin, Heidelberg, Germany
ISBN-10: 3662508079
Pagini: 769
Ilustrații: XXIII, 746 p. 130 illus., 77 illus. in color.
Dimensiuni: 155 x 235 x 39 mm
Greutate: 1.06 kg
Ediția:Softcover reprint of the original 1st ed. 2013
Editura: Springer Berlin, Heidelberg
Colecția Springer
Locul publicării:Berlin, Heidelberg, Germany
Cuprins
Brief historical account of HBOC development.- Physiology of respiration.- Oxygen transport to tissues.- Pathophysiology of acute anemia.- Global blood safety and need for safe blood supply.- Blood transfusion and its limitations.- Scientific basis and design of HBOCs.- HBOCs: a regulatory perspective.- Current HBOC products in development.- Clinical indications and clinical trials of HBOCs.- HBOCs and adverse events observed in clinical trials.- HBOC-mediated vasoactivity and hypertension.- HBOC and oxygen and nitrogen radical mediated toxicity.- HBOCs and clinical laboratory interference.- Animal models for HBOC studies.- New emerging Technologies for universal RBCs.- Future prospects.
Textul de pe ultima copertă
Currently, hemoglobin (Hb)-based oxygen carriers (HBOCs) are leading candidates as red blood cell substitutes. In addition, HBOCs are also potential oxygen therapeutics for treatment of patients with critical ischemic conditions due to atherosclerosis, diabetes and other conditions. This book will provide readers a comprehensive review of topics involved in the HBOC development. It focusses on current products and clinical applications as well as on emerging technologies and future prospects.
Caracteristici
Focus on Hemoglobin-based oxygen carriers (HBOCs) Up to date information on progress of existing products, new emerging products/technologies In-depth treatise covering rationale, scientific and clinical basis, ideal characteristics of HBOCs, approaches to HBOC products, scale up and manufacturing, preclinical and clinical studies for safety and efficacy evaluations, current challenges and future directions Includes supplementary material: sn.pub/extras